Amy Rabourn
2020
In 2020, Amy Rabourn earned a total compensation of $266.7K as Vice President of Finance at Rexahn Pharmaceuticals.
Compensation breakdown
| Bonus | $10,000 |
|---|---|
| Non-Equity Incentive Plan | $9,700 |
| Option Awards | $213,623 |
| Salary | $33,333 |
| Total | $266,656 |
Rabourn received $213.6K in option awards, accounting for 80% of the total pay in 2020.
Rabourn also received $10K in bonus, $9.7K in non-equity incentive plan and $33.3K in salary.
Rankings
In 2020, Amy Rabourn's compensation ranked 12,276th out of 13,090 executives tracked by ExecPay. In other words, Rabourn earned more than 6.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,276 out of 13,090 | 6th |
Division Manufacturing | 5,262 out of 5,621 | 6th |
Major group Chemicals And Allied Products | 2,137 out of 2,254 | 5th |
Industry group Drugs | 1,858 out of 1,954 | 5th |
Industry Pharmaceutical Preparations | 1,381 out of 1,459 | 5th |
Source: SEC filing on April 26, 2021.
Rabourn's colleagues
We found three more compensation records of executives who worked with Amy Rabourn at Rexahn Pharmaceuticals in 2020.